• Explore /
  • Poster
  • / A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171).

A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171).

Abstract Poster

Authors

null

Simon Gollins

North Wales Cancer Treatment Centre, Bodelwyddan, United Kingdom

Simon Gollins , David Sebag-Montefiore , Richard Adams , Mark P. Saunders , Robert Grieve , Nigel Scott , Gina Brown , Philip Quirke , Laura Butlin , Ruby Ray , Gareth Griffiths , Chris Hurt

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT01263171

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3609)

DOI

10.1200/jco.2015.33.15_suppl.3609

Abstract #

3609

Poster Bd #

102

Abstract Disclosures

Similar Posters

First Author: Mark Harrison

First Author: Fulong Wang

First Author: Steven J. Cohen

First Author: Greg Yothers